On May 6, on behalf of the FDA Alumni Association (FDAAA), Catalyst President Nancy Bradish Myers will present former FDA Commissioner Mark McClellan with the 2016 Harvey W. Wiley Lecture Award.

Ms. Myers, who has served as Board Chair for FDAAA since April 2014, will present the award during the Food and Drug Law Institute’s 2016 annual conference. Former Commissioner McClellan, MD, PhD, is currently Director of the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University.

“Mark is an innovative visionary when it comes to exploring complex policy challenges and how to balance government, industry and patient interests,” Ms. Myers said. “Following his leadership roles at FDA and CMS, he is using his unique pedigree to advance the understanding of federal perspectives while taking on the challenges created by today’s evolving healthcare marketplace. He is a smart cookie. I’m privileged to have worked at FDA while he was at the helm, and it’s my honor to present him with this award on behalf of the FDA Alumni Association.”

The Dr. Harvey W. Wiley Lectureship is the FDAAA’s most prestigious external award; it’s named in honor of Dr. Harvey W. Wiley, the renowned physician-chemist who, at the turn of the 20th century, championed a legislative crusade against food adulteration, earning him the title of “Father of the Pure Food and Drugs Act” when it was enacted into law in 1906.

The recipient must be someone who: has promoted public understanding of FDA’s mission; provides intellectually stimulating perspectives on the public health roles of FDA; and considers innovative ways in which FDAAA members can impact the agency’s mission.

Recent Tweets

This is fantastic news Proteus Team! Congrats to you and TennCare. As the importance of remote monitoring is realized- especially during and immediately following this COVID pandemic, TennCare will be seen as an early adopter. This will be an important…https://lnkd.in/erD_A2G

FDA continues working around the clock to combat the #COVID19 pandemic. Here is our latest update: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-14-2020

In @AISHealth, Catalyst’s Jeff Myers weighs in on the #SCOTUS 8-1 ruling of #CMS owing billions to health insurers in risk corridor funding, discussing while it’s mandated by law, the risk corridor program isn’t well designed to begin with. http://catalysthcc.com/2020/05/04/health-insurers-hail-scotus-ruling-in-risk-corridors-case/

In @thehill, Catalyst’s Jeff Myers argues it’s unlikely early #COVID19 treatments will have remarkably high efficacy, but it’s still worth making and having them be available options to combat the deadly #coronavirus. https://thehill.com/policy/healthcare/494936-race-for-coronavirus-vaccine-faces-early-challenges